Hem/Onc Roundup: AI Better Detects Breast Cancer than Radiologists, Apps to Detect Skin Cancer Miss the Mark, and more

Here are the top stories covered by DocWire News this week in the Hematology & Oncology section. This week, a study found that oral cancer mortality risk is increased in patients who drink and smoke, apps to test moles are not detecting skin cancer, and more.

Patients with oral cancer who smoke and drank had higher all‐cause mortality and oral cancer‐specific mortality compared with patients with oral cancer who did not drink or smoke, according to a study published in Head & Neck.

In patients with atrial fibrillation who receive anticoagulants, lower gastrointestinal bleeding is associated with an increased risk of colorectal cancer, according to a study published in the European Heart Journal.

Algorithm-based smartphone apps using artificial intelligence (AI) to test moles are not reliably able to detect melanoma and other skin cancers, according to a study published in The BMJ.

A retrospective study measured the diagnostic value of an AI algorithm to detect breast cancer and found that it outperformed the detection ability of radiologists.

Commonly prescribed medications, cholesterol-lowering statins and the diabetes therapy metformin may have anticancer effects, according to preliminary research published in Cancer Medicine.

In case you missed it, more hem/onc headlines are featured below: